AMGN · News · 20261104N

Operating Income and Margins

AMGEN INC · 2026-11-04 · Importance 13 · Surprise 6

Amgen reported a Q3 2026 non-GAAP operating margin of 47%. Management maintained its full-year 2026 non-GAAP operating-margin outlook at 45% to 46% of product sales. The reported figures do not quantify a year-over-year margin change or identify specific margin drivers.

Key facts

• Amgen's Q3 2026 non-GAAP operating margin was 47%; full-year 2026 non-GAAP operating margin was expected to be roughly 45% to 46% of product sales. source